Device / Technology News

RSS

Drilling technology used to reopen arteries

Then Wilks was referred to Dr. Fred Leya, an interventional cardiologist at Loyola University Health System. Leya used a device similar to a dental drill to reopen three arteries that had turned as hard as bone.

25 Mar 2010

Novel test may help identify newborns with fragile X syndrome

A newly developed test appears highly accurate in identifying newborns with fragile X syndrome—the most common inherited cause of cognitive impairment—as well as identifying couples who are carriers of the causative gene, reports a study in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.

25 Mar 2010

New ultrasound device shows promising results for treating joint and muscle pain

It's lightweight, smaller than most iPods and can deliver low-intensity ultrasound therapy for up to 10 hours. It just might revolutionize pain relief - and save patients time.

25 Mar 2010

ZK Software's dual biometric reader verifies identity in less than two seconds

ZK Software, a leading global developer of innovative advanced facial and fingerprint biometric and RFID reader solutions, introduced the world's first dual Biometric Reader today at booth # 36017/19 at ISC West in Las Vegas.

25 Mar 2010

Axis Surgical's EC-MOR facilitated real-time visualization of anterior spine column during surgery

Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR™ Visualization Device in a spine procedure. The C-MOR™ is a self-contained portable direct-imaging tool that functions much like a standard arthroscopic tower, yet at a fraction of both the size and cost. The handheld lightweight device offers practitioners the convenience of intraoperative visualization and complete operability in one hand. The C-MOR™ comprises a distinctive and cost-effective imaging device offering benefits to medical practitioners in a variety of applications, including lengthy surgeries requiring constant re-evaluation of the operating field over the course of the surgery.

25 Mar 2010

Committee recommends inclusion of genetic diseases in newborn screening program

The experts who make recommendations for genetic disease screening in newborns face a challenging task: To make conclusions based on the most authoritative available evidence, while considering gaps in the research on such rare conditions, as well as their human impact. An overview of the steps followed by the expert panels tasked with making these recommendations is presented in a special section of the current issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.

25 Mar 2010

US patent reinforces Ikonisys' position in digital image-analysis industry

Ikonisys, Inc., a leading provider of next-generation, cell-based diagnostic solutions, announced today that the United States Patent and Trademark Office has issued the company United States Patent No. 7,660,454 entitled “Process for identifying FISH signals.”

25 Mar 2010

Biocompatible electronics could enable new surgical applications

Arrhythmic hearts soon may beat in time again, with minimal surgical invasion, thanks to flexible electronics technology developed by a team of University of Illinois researchers, in collaboration with the University of Pennsylvania School of Medicine and Northwestern University.

25 Mar 2010

AGA Medical gets IDE approval to evaluate AMPLATZER Cardiac Plug

AGA Medical Holdings, Inc. today announced it has received conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration to evaluate the safety and efficacy of its AMPLATZER® Cardiac Plug, or ACP, to close the left atrial appendage.

25 Mar 2010

New series of filters screen compounds for drug development

The identification of compounds that could be promising candidates for drug development has become easier following research by the Walter and Eliza Hall Institute's medicinal chemistry group.

25 Mar 2010

FDA approves Custom Spine's anterior cervical interbody device

Custom Spine announced today that it has received FDA clearance to market PATHWAY ACIF, an anterior cervical interbody spacer. This cervical interbody device compliments the company's low-profile anterior cervical plate system, Regent ACP, which was released this past November.

25 Mar 2010

Agendia brings new personalized treatment for breast cancer patients

Agendia, a world leader in molecular cancer diagnostics, today announced that its breast cancer product offering, consisting of breast cancer recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with BluePrint (TM) to report important additional information on tumor subtypes.

24 Mar 2010

Stretchable electronic device holds promise for treating irregular heart rhythms

The electronics can bend, stretch and twist. No small feat. Now the flexible and stretchable electronics can map waves of electrical activity in the heart with better resolution and speed than that of conventional cardiac monitoring technology.

24 Mar 2010

New Motion Traxx iPhone App for fitness activities

Wizzard Media, announced the availability today of the Motion Traxx iPhone App in the App Store. Following the success of the Motion Traxx podcast, downloaded over 2 million times in its first year and currently ranked 7th in the iTunes podcast Health category and 138th of all podcasts in iTunes, the Motion Traxx iPhone App is a powerful motivator for exercise and makes meeting fitness goals easier.

24 Mar 2010

New, portable EEG-based device for people with motoric disabilities

Imec, Holst Centre and the lab of Neuro- and Psychophysiology at the Katholieke Universiteit Leuven today present the Mind Speller, a portable, easy-to-wear, intelligent textual and verbal communications prototype device enabling people with motoric disabilities (suffering from for example brain paralysis or speech or language disorders) to communicate.

24 Mar 2010

Abbott/Eisai's Humira termed as most efficacious therapy for psoriasis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed dermatologists view Abbott/Eisai's Humira as the most efficacious therapy for the treatment of moderate to severe psoriasis. Thirty-two percent of surveyed dermatologists selected Humira as the most efficacious, followed by Centocor Ortho Biotech/Merck/Mitsubishi Tanabe's Remicade. The current sales leader Amgen/Pfizer/Takeda's Enbrel was selected as the most efficacious therapy by only 23 percent of dermatologists surveyed.

24 Mar 2010

TYRX begins enrollment in CITADEL study for Aigisrx anti-bacterial agent

TYRX, Inc., a leader in the commercialization of implantable medical devices designed to help reduce infection, announced today that it has begun enrollment in CITADEL, the second of two large scale, prospective, multicenter studies.

24 Mar 2010

UNDT's 5-agent bioterrorism detection kits used by first responders

Universal Detection Technology, a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, issued a response today to a growing interest in the security and emergency response communities to immunize first responders most susceptible to anthrax exposure.

24 Mar 2010

Skinvisible obtains Korean patent for polymer delivery system

Skinvisible, Inc. announced today that the South Korean patent office has granted a patent for Invisicare®, the company's polymer delivery system for topical dermatology products.

24 Mar 2010

Brain imaging technique may help predict effects of strokes and other brain injuries

Clinicians may be able to better predict the effects of strokes and other brain injuries by adapting a scanning approach originally developed for study of brain organization, neurologists at Washington University School of Medicine in St. Louis have found.

24 Mar 2010